It has been demonstrated that Ptn-/- mice exhibit exacerbated amphetamine-induced dopaminergic injury in the nigrostriatal pathway (Gramage et al., 2010), which correlated with changes in the striatal phosphoproteome similar to those found in PD (Gramage et al., 2013). This evidence concerns the gene PTN and Parkinson disease.